These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 6668481

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cancer chemotherapy via ambulatory infusion pump.
    Lokich JJ, Perri J, Bothe A, Zipoli T, Philips D, Sonneborn H, Paul S, Green R.
    Am J Clin Oncol; 1983 Jun; 6(3):355-63. PubMed ID: 6405610
    [Abstract] [Full Text] [Related]

  • 3. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Jun; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 4. Feasibility study of combining metronidazole with chemotherapy.
    Stewart DJ, Maroun JA, Young V, Crook AF, Hopkins HS, Yan RC, Richard MT, Hugenholtz H, Bélanger R, Heringer R.
    J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The delivery of cancer chemotherapy by constant venous infusion. Ambulatory management of venous access and portable pump.
    Lokich J, Bothe A, Fine N, Perri J.
    Cancer; 1982 Dec 15; 50(12):2731-5. PubMed ID: 6890403
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T, Niitani H, Furue H, Tsukagoshi S, Kanamaru R, Hasegawa K, Akazawa S, Yoneda S, Tominaga T, Sasaki T.
    Gan To Kagaku Ryoho; 1995 Feb 15; 22(2):259-71. PubMed ID: 7857102
    [Abstract] [Full Text] [Related]

  • 12. Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule.
    Feun LG, Savaraj N, Bodey GP, Lu K, Yap BS, Ajani JA, Burgess MA, Benjamin RS, McKelvey E, Krakoff I.
    Cancer Res; 1984 Aug 15; 44(8):3608-12. PubMed ID: 6744283
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer.
    Legha SS, Benjamin RS, Mackay B, Yap HY, Wallace S, Ewer M, Blumenschein GR, Freireich EJ.
    Cancer; 1982 May 01; 49(9):1762-6. PubMed ID: 7074581
    [Abstract] [Full Text] [Related]

  • 16. Clinical effects and pharmacokinetics of different dosage schedules of adriamycin.
    Creasey WA, McIntosh LS, Brescia T, Odujinrin O, Aspnes GT, Murray E, Marsh JC.
    Cancer Res; 1976 Jan 01; 36(1):216-21. PubMed ID: 942583
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A phase of I trial of 4'-epi-Adriamycin.
    Schauer PK, Wittes RE, Gralla RJ, Casper ES, Young CW.
    Cancer Clin Trials; 1981 Jan 01; 4(4):433-7. PubMed ID: 7318126
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.